Revance Therapeutics
RVNC shares dipped 28.33% to $15.05 after the company reported a Q3 net loss of $14.0 million, versus a year-ago loss of $8.9 million.
Local
LOCM shares fell 24.63% to $1.30 after the company reported a Q3 loss of $0.06 per share on revenue of $18.10 million and issued a weak sales forecast.
La Jolla Pharmaceutical Co
LJPC dropped 11.04% to $11.69 after the company reported a Q3 loss of $0.37 per share and reported that primary endpoint for Phase 2 trial of GCS-100 was met.
SunPower
SPWR- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
tumbled 7.53% to $26.95 after the company issued FY15 guidance. For fiscal year 2015, the company expected net income per diluted share of $1.10 to $1.50 on non-GAAP revenue of $2.4 billion to $2.6 billion.
J. C. Penney Company
JCP shares slipped 9.54% to $7.02 after the company reported a narrower-than-expected third-quarter loss, but its sales were slightly below the Wall Street consensus. The company also posted flat same-store sales in the quarter.
Regulus Therapeutics
RGLS shares tumbled 9.49% to $17.76 after falling 4.15% on Wednesday.
Texas Capital BancShares
TCBI slipped 3.14% to $59.80 after the company priced 2.5 million common stock offering.
Kohl's
KSS dipped 2.02% to $56.74 after the company reported weaker-than-expected fiscal third-quarter profit.
Loading...
Loading...
KSSKohl's Corp
$8.962.34%
Edge Rankings
Momentum
7.23
Growth
13.88
Quality
36.65
Value
95.72
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in